Stocks
Editas Medicine, Inc.EDIT
NASDAQHealthcareBiotechnology$2.70-3.94%
Price as of · delayed, not real-time
A clinical-stage biotechnology company focused on developing transformative gene-editing therapies using CRISPR technology. Its pipeline targets genetic diseases, including sickle cell disease and beta-thalassemia, attracting investor interest due to its potential to disrupt traditional treatment paradigms.
Market Cap: $238.8M52W Range: $1.66-$4.54
Congressional Interest in Editas Medicine, Inc. (EDIT)
6 members of Congress have disclosed 21 trades in Editas Medicine, Inc. (EDIT), a Healthcare company. The buy/sell breakdown shows 11 purchases versus 10 sales, indicating net buying interest from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
21
Unique Politicians
6
Buys
11
Sells
10
Who in Congress Is Trading EDIT?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2023-04-10 | Daniel Goldman | sell | $1K-$15K |
| 2021-04-14 | Donald Sternoff Beyer | sell | $1K-$15K |
| 2021-03-02 | Donald Sternoff Beyer | sell | $1K-$15K |
| 2021-01-19 | William F Hagerty, IV | sell | $15K-$50K |
| 2020-11-17 | Donald Sternoff Beyer | buy | $1K-$15K |
| 2020-05-01 | Donald Sternoff Beyer | sell | $1K-$15K |
| 2020-04-27 | Donald Sternoff Beyer | sell | $1K-$15K |
| 2020-01-27 | Donald Sternoff Beyer | buy | $1K-$15K |
| 2020-01-09 | Donald Sternoff Beyer | buy | $1K-$15K |
| 2019-12-23 | Donald Sternoff Beyer | buy | $1K-$15K |
| 2019-12-09 | Donald Sternoff Beyer | buy | $1K-$15K |
| 2019-11-22 | Donald Sternoff Beyer | buy | $1K-$15K |
| 2019-11-19 | Donald Sternoff Beyer | buy | $1K-$15K |
| 2019-06-17 | CHARLES J. "CHUCK" FLEISCHMANN | sell | $1K-$15K |
| 2019-06-04 | Donna Shalala | sell | $1K-$15K |
| 2019-05-21 | CHARLES J. "CHUCK" FLEISCHMANN | sell | $1K-$15K |
| 2019-03-06 | Donna Shalala | buy | $1K-$15K |
| 2019-02-04 | James M Inhofe | sell | $15K-$50K |
| 2018-04-06 | CHARLES J. "CHUCK" FLEISCHMANN | buy | $15K-$50K |
| 2017-11-17 | CHARLES J. "CHUCK" FLEISCHMANN | buy | $1K-$15K |
| 2017-10-19 | James M Inhofe | buy | $15K-$50K |